National Institute of General Medical Sciences; Notice of Meeting, 76059 [2012-30899]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 247 / Wednesday, December 26, 2012 / Notices
Dated: December 18, 2012.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–30902 Filed 12–21–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
tkelley on DSK3SPTVN1PROD with
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory General Medical
Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: January 24–25, 2013.
Closed: January 24, 2013, 8:30 a.m. to 5:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Open: January 25, 2013, 8:30 a.m. to
Adjournment.
Agenda: For the discussion of program
policies and issues, opening remarks, report
of the Acting Director, NIGMS, and other
business of the Council.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Ann A. Hagan, Ph.D.,
Associate Director for Extramural Activities,
NIGMS, NIH, DHHS, 45 Center Drive, Room
2AN24H, MSC 6200, Bethesda, MD 20892,
(301) 594–4499, hagana@nigms.nih.gov.
VerDate Mar<15>2010
06:31 Dec 22, 2012
Jkt 229001
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit. Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/About/Council/where an
agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research, National Institutes of Health, HHS)
Dated: December 17, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–30899 Filed 12–21–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
76059
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: National Outcome
Measures (NOMs) for Substance Abuse
Prevention—(OMB No. 0930–0230)—
Revision
This is a revision to the previously
OMB approved instrument for the
Center for Substance Abuse Prevention’s
(CSAP) National Outcome Measures for
Substance Abuse Prevention (NOMs).
Data are collected from SAMHSA/CSAP
grants and contracts where community
and participant outcomes are assessed.
The analysis of these data helps
determine whether progress is being
made in achieving SAMHSA/CSAP’s
mission. The primary purpose of this
system is to promote the use among
SAMHSA/CSAP grantees and
contractors of common National
Outcome Measures recommended by
SAMHSA/CSAP with significant input
from panels of experts and state
representatives.
Approval of this information
collection will allow SAMHSA to
continue to meet Government
Performance and Results Modernization
Act of 2010 (GPRAMA) reporting
requirements that quantify the effects
and accomplishments of its
discretionary grant programs which are
consistent with OMB guidance, and
address goals and objectives outlined in
the Office of National Drug Control
Policy’s Performance Measures of
Effectiveness.
Note that the only changes is the
deletion of one question per instrument,
the deletion of prior Fiscal Years, and
the PPC program which was not funded.
The question being deleted is
Has the Service Member experienced
any of the following (select all that
apply)
(a) Deployed in support of combat
operations (e.g. Iraq or Afghanistan)
(b) Was physically injured during
combat operations
(c) Developed combat stress
symptoms/difficulties adjusting
following deployment, including
PTSD, depression, or suicidal
thoughts
(d) Died or was killed
The total annual burden estimate is
shown below:
E:\FR\FM\26DEN1.SGM
26DEN1
]]>Agencies
[Federal Register Volume 77, Number 247 (Wednesday, December 26, 2012)]
[Notices]
[Page 76059]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30899]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory General Medical Sciences Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory General Medical Sciences
Council.
Date: January 24-25, 2013.
Closed: January 24, 2013, 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892.
Open: January 25, 2013, 8:30 a.m. to Adjournment.
Agenda: For the discussion of program policies and issues,
opening remarks, report of the Acting Director, NIGMS, and other
business of the Council.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Ann A. Hagan, Ph.D., Associate Director for
Extramural Activities, NIGMS, NIH, DHHS, 45 Center Drive, Room
2AN24H, MSC 6200, Bethesda, MD 20892, (301) 594-4499,
hagana@nigms.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit. Information is also available on the Institute's/Center's
home page: https://www.nigms.nih.gov/About/Council/where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research,
National Institutes of Health, HHS)
Dated: December 17, 2012.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-30899 Filed 12-21-12; 8:45 am]
BILLING CODE 4140-01-P
